br Fries E Hesse J
29. Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism. Psychoneuroendocrinology. 2005;30:1010–1016. 30. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35. 31. Riva R, Mork PJ, Westgaard RH, Rø M, Lundberg U. Fibromyalgia syndrome is as-sociated with hypocortisolism. Int J Behav Med. 2010;17:223–233. 32. Incollingo Rodriguez AC, Epel ES, White ML, Standen EC, Seckl JR, Tomiyama AJ. Hypothalamic-pituitary-adrenal axis dysregulation and Echinomycin activity in obesity: a systematic review. Psychoneuroendocrinology. 2015;62:301–318.
33. Weinrib AZ, Sephton SE, DeGeest K, et al. Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer. 2010;116:4410–4419.
34. Chiodini I, Torlontano M, Scillitani A, et al. Association of subclinical hypercorti-solism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol. 2005;153:837–844.
35. Abercrombie HC, Giese-Davis J, Sephton S, Epel ES, Turner-Cobb JM, Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology. 2004;29:1082–1092. 36. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000. 37. Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology. 2005;30:92–100. 38. McGregor BA, Antoni MH. Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological med-iators. Brain Behav Immun. 2009;23:159–166.
39. Porter LS, Mishel M, Neelon V, Belyea M, Pisano E, Soo MS. Cortisol levels and re-sponses to mammography screening in breast cancer survivors: a pilot study. Psychosom Med. 2003;65:842–848.
40. Anderson T, Wideman L. Exercise and the cortisol awakening response: a systematic review. Sports Med Open. 2017:3. 41. Gatti R, De Palo EF. An update: salivary hormones and physical exercise. Scand J Med Complementary Therapies in Medicine 42 (2019) 12–18
42. Salimetrics. Salivary secretory IgA enzyme immunoassay kit. Carlsbad, CA, USA: Salimetrics; 2015. 43. Kirschbaum C, Pirke KM, Hellhammer DH. The’ Trier Social Stress Test’–a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 1993;28:76–81.
44. Dumbell R, Matveeva O, Circadian Clocks Oster H. Stress, and immunity. Front Endocrinol. 2016;7:37. 45. Allen AP, Kennedy PJ, Cryan JF, Dinan TG, Clarke G. biological and psychological markers of stress in humans: focus on the trier social stress test. Neurosci Biobehav Rev. 2014;38:94–124. 46. Hellhammer J, Schubert M. The physiological response to trier social stress test re-lates to subjective measures of stress during but not before or after the test. Psychoneuroendocrinology. 2012;37:119–124.
47. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone con-centration versus time-dependent change. Psychoneuroendocrinology. 2003;28:916–931.
50. Brumby S, Chandrasekara A, Kremer P, Torres S, McCoombe S, Lewandowski P. The eﬀect of physical activity on psychological distress, cortisol and obesity: results of the farming fit intervention program. BMC Pub Health. 2013;13:1018.
55. Davies CT, Few JD. Eﬀects of exercise on andrenocortical function. J Appl Physiol. 1973;35:887–891. 56. Hill EE, Zack E, Battaglini C, Viru M, Viru A, Hackney AC. Exercise and circulating cortisol levels: the intensity threshold eﬀect. J Endocrinol Invest. 2008;31:587–591. 57. McMurray RG, Hackney AC. Endocrine responses to exercise and training. Exercise and sport science. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:35–61. 58. Costa RJS, Jones GE, Lamb KL, Coleman R, Williams JHH. The eﬀects of a high carbohydrate diet on cortisol and salivary immunoglobulin A (s-IgA) during a period of increase exercise workload amongst olympic and ironman triathletes. Int J Sports Med. 2005;26:880–885. 59. Hackney AC. Stress and the neuroendocrine system: the role of exercise as a stressor and modifier of stress. Expert Rev Endocrinol Metab. 2006;1:783–792.
63. Henson RK, Smith AD. State of the art in statistical significance and eﬀect size re-porting: a review of the APA task force report and current trends. J Res Dev Edu. 2000;33:285–296. 64. Kline RB. Beyond significance testing: Reforming data analysis MEthods in behvaioral